These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 795170

  • 1. [Treatment of advanced respiratory insufficiency using potassium canreonate (Aldactone). Preliminary report].
    Kerjaschki A.
    Wien Med Wochenschr; 1976 Dec 03; 126(49-50):705-7. PubMed ID: 795170
    [No Abstract] [Full Text] [Related]

  • 2. [Potassium canreonate in neurosurgical brain edema].
    Mille T, Rodriguez R, Baena Y.
    Minerva Chir; 1976 Dec 03; 30(13-14):781-9. PubMed ID: 1221307
    [Abstract] [Full Text] [Related]

  • 3. [Therapeutic effect of fominoben in obstructive respiratory disorders and respiratory insufficiency].
    Uhl O.
    Arzneimittelforschung; 1973 Feb 03; 23():Suppl 2a:338-4. PubMed ID: 4575175
    [No Abstract] [Full Text] [Related]

  • 4. [Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
    Kirsch R.
    Schweiz Rundsch Med Prax; 1975 Nov 04; 64(44):1414-7. PubMed ID: 1236699
    [No Abstract] [Full Text] [Related]

  • 5. [Plasma hyperosmolarity aspects in intensive care and its treatment with potassium canreonate].
    Ruggerini R, Mazzocchi F, Albini G, Cifalinò M.
    Minerva Anestesiol; 1979 Sep 04; 45(9):687-90. PubMed ID: 117400
    [Abstract] [Full Text] [Related]

  • 6. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M, Vizzini GB.
    Minerva Med; 1986 Jan 28; 77(3-4):87-91. PubMed ID: 3511409
    [Abstract] [Full Text] [Related]

  • 7. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F, Ferraù O, Pitrone F, Luzza G, Russo A, Virga T.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract] [Full Text] [Related]

  • 8. [Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
    Russo R, Schena FP, Colombo Pirola L.
    Clin Ter; 1984 Apr 15; 109(1):23-9. PubMed ID: 6233076
    [No Abstract] [Full Text] [Related]

  • 9. Clinical study of potassium canrenoate on raised intracranial pressure.
    Node Y, Nakazawa S.
    Adv Neurol; 1990 Apr 15; 52():557. PubMed ID: 2396562
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.
    Cristodorescu R, Puschita M, Deutsch G, Berger E, Luca C.
    Med Interne; 1977 Apr 15; 15(1):27-34. PubMed ID: 841250
    [Abstract] [Full Text] [Related]

  • 12. Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.
    Waldorff S, Buch J.
    Eur J Cardiol; 1979 Aug 15; 10(2):143-9. PubMed ID: 477703
    [Abstract] [Full Text] [Related]

  • 13. [Use of potassium canrenoate in cardiosurgery].
    Tufano R, Scopa M, Brando G, Leone D.
    Minerva Anestesiol; 1981 Apr 15; 47(4):149-54. PubMed ID: 7242963
    [Abstract] [Full Text] [Related]

  • 14. Treatment of digitalis toxicity with intravenous potassium canrenoate.
    Gavrilescu G, Cristodorescu R, Deutsch G, Berger E.
    Agressologie; 1977 Apr 15; 18(3):167-71. PubMed ID: 920909
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Aldosterone antagonists in coronary insufficiency].
    Osswald H.
    Med Klin; 1978 Jan 20; 73(3):84-8. PubMed ID: 622061
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.